iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
5.98
-0.34 (-5.38%)
Mar 31, 2025, 1:37 PM EDT - Market open
iTeos Therapeutics Market Cap
iTeos Therapeutics has a market cap or net worth of $228.40 million as of March 31, 2025. Its market cap has decreased by -43.96% in one year.
Market Cap
228.40M
Enterprise Value
-261.53M
1-Year Change
-43.96%
Ranking
Category
Stock Price
$5.98
Market Cap Chart
Since July 24, 2020, iTeos Therapeutics's market cap has decreased from $636.93M to $228.40M, a decrease of -64.14%. That is a compound annual growth rate of -19.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 241.39M | -13.97% |
| Dec 31, 2024 | 280.58M | -28.40% |
| Dec 29, 2023 | 391.85M | -43.60% |
| Dec 30, 2022 | 694.79M | -57.70% |
| Dec 31, 2021 | 1.64B | 38.57% |
| Dec 31, 2020 | 1.19B | 86.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |